How Much Is A Service Call Disc Surgery Worth
Spine (Phila Pa 1976). Writer manuscript; available in PMC 2015 Oct xv.
Published in final edited grade as:
PMCID: PMC4487880
NIHMSID: NIHMS619571
Setting the Equation: Establishing Value in Spine Care
Anna North. A. Tosteson
(a)James J. Carroll Professor, Multidisciplinary Clinical Research Center in Musculoskeletal Diseases, The Dartmouth Establish for Health Policy and Clinical Practice, Geisel School of Medicine at Dartmouth, Lebanese republic, NH 03756
Rachel F. Groman
(b)Vice president, Clinical Diplomacy and Quality Comeback, Hart Health Strategies, 3823 Fordham Road, NW, Washington, DC 20016
Zoher Ghogawala
(c)Charles A. Fager Chairman, Department of Neurosurgery, Associate Professor, Tufts University Schoolhouse of Medicine, Co-Managing director, Lahey Comparative Effectiveness Research Institute Lahey Hospital and Medical Center, 41 Mall Route, Burlington, Massachusetts 01805
Abstruse
Objective
Describe value measurement in spine care and discuss the motivation for, methods for, and limitations of such measurement.
Summary of Background Data
Spinal disorders are common and are an important cause of pain and inability. Numerous complimentary and competing treatment strategies are used to treat spinal disorders and the costs of these treatments is substantial and continues to rising despite articulate evidence of improved health status as a result of these expenditures.
Methods
The authors present the economic and legislative imperatives forcing the assessment of value in spine intendance. The definition of value in health care and methods to measure value specifically in spine care are presented. Limitations to the utility of value judgements and caveats to their use are presented.
Results
Examples of value calculations in spine care are presented and critiqued. Methods to improve and broaden the measurement of value across spine care are suggested and the office of prospective registries in measuring value is discussed.
Conclusions
Value tin can be measured in spine care through the use of appropriate economic measures and patient reported outcomes measures. Value must exist interpreted in lite of the perspective of the assessor, the elapsing of the assessment menstruum, the degree of advisable take a chance stratification, and the relative value of treatment alternatives.
Keywords: Value, QALY, Inability, Functional Outcome, Lumbar Fusion
Introduction
Spine intendance is a focus of cost and quality efforts in the United States and throughout the globe for several of import reasons. First, spinal disorders and disability due to spinal disorders are very common. In the 2010 Global Brunt of Disease Study, of the 291 weather studied, low back pain was ranked highest in terms of years lost to disability with 83 million inability adjusted life years lost attributed to low back hurting in 2010 (1). Second, intendance of spinal disorders is very expensive. In the The states, half dozen% of adults meet a doctor for a back and neck complaint every yr and the costs associated with these visits has doubled over the past decade, with concrete therapy costs increasing most dramatically (2). Martin et al analyzed Medical Expenditure Panel Survey data from 22,258 respondents in 2005. Of these respondents, 3187 reported spine problems and those respondents who reported spine problems indicated that their medical costs were nearly twice that of respondents who did not report back or cervix complaints ($4695 versus $2731) (iii). These costs continue to increase despite a lack of data to indicate that these increased costs are associated with improved outcomes.
Complicating the effect is the fact that there are multiple unlike treatment strategies for spinal disorders. A quick literature search using the terms "low back pain" and "inability" performed in Apr, 2014 yielded papers describing the effectiveness and/or cost effectiveness of deep tissue massage, accupunture, whole trunk vibration exercise, manipulation under anesthesia, percutaneous adhesiolysis, core stability practice, lumbar mobility exercise, pars interarticularis injections, epidural steroid injections, therapeutic ultrasound, microwave diathermy, cognitive therapy, balneotherapy, nucleoplasty, and the use of various surgically implanted non-fusion devices (4–16). These all appeared inside the top 40 most contempo references, and do non fifty-fifty include the unremarkably employed strategies for dorsum hurting such equally chiropractic intendance, lumbar fusion, cognitive therapy, or medical management.
Clearly, there is a demand to define the value of these different interventions in order to make judgements regarding the relative worth of these disparate treatments in different patient populations. The purpose of this newspaper is to explore the definitions of value, propose several mechanisms for the assessment of value, draw the limitations of these definitions and mechanisms, and to discuss some of the regulatory imperatives that are accelerating the pace of measurement despite best-selling limitations in the ability of practitioners to define, allow lonely measure value in spine intendance. A glossary of usually used terms is provided to help the clinician with unfamiliar terms.
Definitions of value in healthcare
For individuals affected past spine problems, the option between operative and non-operative intendance is often viewed as a "preference-sensitive" decision —one that should hinge on how a patient feels about their current land of health relative to the risks and benefits of undergoing surgery. Informed conclusion making requires that patients fully empathize the treatment alternatives and that they make choices that are aligned with their preferences for the benefits and harms of each possible treatment.
Preference for wellness may exist formally measured using the concept of health utility where each wellness state is assigned a value or preference weight on a scale where ane represents best imaginable health and 0 represents worst imaginable health or expiry. Information technology is noteworthy that any two individuals with considerately equivalent wellness-related quality of life based on a health status measure such as the SF-36 may view their health quite differently and assign dissimilar utilities. There are a number of means to arm-twist wellness utility ranging from direct utility assessment with a standard hazard, time tradeoff or visual analog scale, to preference-weighted wellness state classification systems such as the EuroQol EQ-5D or Health Utilities Index (HUI).
Valuing spine treatments requires measuring how care affects patients' health-related quality of life. This is critically important because many spine weather for which care is performed do not extend life. Instead, they improve patient's health-related quality of life—their power to function without pain in carrying out their daily activities. To assess the value of interventions that impact quality, not but length of life, it is critically important to have an issue measure that characterizes the quality of life dimension.
The QALY
The quality-adapted life year (QALY) is the most widely used effectiveness measure that combines length and quality of life into a unmarried number (17). QALYs were developed every bit a measure for use in economical evaluation in health and medicine more than than 30 years agone (18, 19).
QALYs are typically estimated by multiplying the amount of time spent in each wellness state by each state'southward health utility and summing up. For example, if i were to spend the next ten years with 5 years in perfect wellness, three years with limited mobility and 2 years with limited mobility and moderate pain and these wellness states had respective utilities of ane.0, 0.85 and 0.7, this would be equivalent to 8.95 QALYs (5x1 + 3x0.85 + 2x0.7=8.95).
Societal Values and Cost-effectiveness Analysis
The Panel on Price-effectiveness in Wellness and Medicine recommends that QALYs be used to measure out the effectiveness in economic evaluations of health care interventions (20). Measuring effectiveness in terms of cost per QALY gained has the advantage of allowing comparisons of the value of healthcare interventions across a wide assortment of health domains. For instance, the effectiveness and value of interventions for spinal disorders may be compared directly with cardiovascular illness interventions. The literature on the price-effectiveness of diverse healthcare interventions is catalogued in the Tufts School of Medicine Cost-effectiveness Analysis Registry (https://research.tufts-nemc.org/cear4/SearchingtheCEARegistry/SearchtheCEARegistry.aspx).
To evaluate the cost-effectiveness of competing health care interventions, an incremental toll-effectiveness analysis is required with the incremental cost-effectiveness ratio (ICER) serving every bit the price-effectiveness measure. The ICER is defined as the change in price divided by the change in effectiveness for each more than plush alternative when they are ranked from everyman to highest cost ( ICER= (C2-C1)/ (QALYii-QALY1)). When the costs of alternative care strategies are plotted confronting their estimated effectiveness (Figure 1), the gradient of the line between strategies is the ICER.
Figure: Graphical representation of incremental cost-effectiveness ratio (ICER) for Strategy 2 relative to Strategy 1 when strategy costs are plotted against the QALYs associated with each strategy.
While information technology is widely accepted that the individual patient'southward preferences and health utilities should guide his or her decision making, when assessing the cost-effectiveness of healthcare interventions, it is societal preferences for health outcomes rather than the preferences of those directly affected that are considered appropriate. Preference classification systems, such as EQ-5D and HUI, measure health condition in individuals with the health condition of interest, but assign a societal wellness state value to each wellness state defined within the organisation on the basis of a scoring algorithm (20). This approach for valuing spine surgery was used in the Spine Patient Outcomes Research Trial (SPORT), which has assessed the cost-effectiveness of spine surgery relative to non-operative intendance for patients with intervertebral disc herniation, spinal stenosis and degenerative spondylolisthesis (21, 22, 23).
Economic analysis in Spine Outcomes Research
The importance of value when assessing spine treatments is becoming more than important non only because of a need to command health care expenditures in general, but likewise because many recognize that higher quality might be associated with lower cost. Indeed comparative effectiveness research tin not really exist separated from price-effectiveness enquiry when information technology comes to spinal disorders. It is mostly agreed that an economic analysis must compare costs per QALY gained for i treatment versus an alternative. While each society must ultimately decide on what they are willing to pay for an additional QALY for 1 individual, in the US a ordinarily used price-effectiveness benchmark is $ 100,000/ QALY gained. (24).
The complexity comes from the adding of cost and from what perspective. Healthcare charges are oft used equally a surrogate for healthcare costs because charges tin readily exist obtained from administrative databases. Charges from inpatient authoritative databases such as the national inpatient sample are inflated and practice non correspond actual costs or even reimbursement. Applying cost-to-charge ratios (25) or calculating reimbursement using Medicare's values (26) are commonly used techniques for estimating actual costs. Costs must be calculated not just for an episode of hospital care, but over a reasonable fourth dimension horizon from a societal perspective and must include directly inpatient and outpatient wellness costs (hospital, chemist's, professional, radiology, lab testing, etc.) and indirect health costs (due east.g. lost productivity and missed work for the patient and his/her caregivers). These types of economical assessments by and large require the expertise of healthcare economists.
The SPORT trials included an economic assay that permitted the assessment of cost-effectiveness for surgical therapy versus non-operative therapy for lumbar disc illness, lumbar spinal stenosis, and lumbar spondylolisthesis. Two major concepts emerged from this assay. Cost-effectiveness for lumbar discectomy versus non-operative treatment at 2 years was $ 69,403/ QALY gained (all payers), but a significantly different figure was generated ($34,355/ QALY gained) when Medicare-specific reimbursement costs were utilized (27). The disquisitional importance of fourth dimension horizon was besides observed. For example, surgery versus non-operative treatment for lumbar spondylolisthesis was above the $ 100,000/ QALY threshold at two years ($ 115,600/ QALY) (28) but fell beneath the ordinarily accustomed to pay threshold at four years ($ 64,300/ QALY)(29). Clearly, the choice of methodology affects the results of an economic assay. Studies comparison more than costly upfront treatments (e.chiliad. surgery) can be compared to less costly upfront treatments over an appropriate time horizon that permits the immovability of treatments to be compared.
The importance of time horizon is illustrated well in a study by Soegaard et al that compared circumferential lumbar fusion versus posterolateral lumbar fusion (30). The study found an incremental savings of $ 49,306/ QALY for patients treated with circumferential fusion versus posterolateral fusion over an 8 yr time horizon. The circumferential fusion cohort had a college fusion rate and had a fifteen% re-operation charge per unit versus a 38% re-performance charge per unit observed in the posterolateral cohort. Circumferential fusion was associated with superior functional outcomes just the long follow-upwardly menstruum demonstrated the overall price-effectiveness considering the circumferential fusion appeared to be more than durable than the posterolateral only fusion cohort.
The increased utilization of recombinant human bone morphogenetic proteins (rhBMPs) equally a fusion enhancer has attracted widespread attention for its potential risks and its costs. Administrative data using hospital charge data finds that spinal fusion with rhBMP is associated with an average hospital charge of $ 74,254 compared to $ 57,393 for spinal fusions without rhBMP (31). These data do not contain comparable populations nor do they include outcomes or QALY data. Many studies take compared the toll of iliac crest bone graft to rhBMP for lumbar fusion and have plant similar actual hospital costs (32, 33); all the same, without comparing differences in overall outcome and including outpatient and societal costs, the cost-effectiveness of rhBMP is largely not known.
Equally more than new implants and devices enter the spine marketplace, it will be imperative that comparative outcomes research incorporate comprehensive cost evaluations. Computing health costs from a societal perspective and comparing costs over time will enable investigators, payers, and policy makers to make rational decisions about the comparative cost-effectiveness of diverse options in spinal treatments going forrard.
Legislative and Regulatory Imperatives
In the decade leading up to the signing of the Affordable Care Act (ACA), in that location was a growing sense of urgency within the public and private sector to create a more sustainable healthcare organization. Some of this pressure came from documented shortfalls in U.Southward. health outcomes, which lagged sorely backside other developed nations. Other pressure came from groundbreaking estimates of medical error ubiquity and patient harm. (34, 35) But while these lapses in quality made headlines and defenseless the nation'south attention, the larger impetus for health reform was the growing disconnect between spending and quality. For over a decade leading upward to the ACA, healthcare spending had been growing at a charge per unit greater than the nation's overall economy, (36) and by 2009, it was estimated that near 30 pct of healthcare spending was wasteful (37).
Responding to what was less of an opportunity and more of a mandate for change, the ACA, and other legislation leading up to it, presented physical plans to leverage federal ownership power and reduce expenditures through the pursuit of high-value care. In fact, the term "value" is used over 200 times throughout the text of the ACA (38) to characterize a range of provisions aimed at reducing waste on multiple fronts. Targets include spending on items and services that lack evidence of producing improve outcomes; costs that effect from avoidable medical injuries, such as preventable infections in hospitals; fraud and abuse; and overall inefficiencies in the provision of health intendance goods and services.
These new initiatives accept aim at foundational features of the Medicare payment arrangement that, to date, take discouraged efficiencies and posed as impediments to higher value care. A usually critiqued feature is the fee-for-service approach to doctor payment, which incentivizes book over quality. While FFS still remains, programs such as the Md Quality Reporting Arrangement (PQRS) and the more contempo Physician Value-based Payment Modifier (VBM) represent a shifting prototype nether which physicians are increasingly scrutinized and held accountable for both the quality and toll of their care. Together, these programs could issue in cuts to doctor payments approaching −x% in future years. The severity of these cuts is compounded by the fact that these programs rely on capricious functioning thresholds, rudimentary risk adjustments and attribution methodologies, and measures that are only tenuously relevant and meaningful to the spine surgeon.
Medicare'south inpatient infirmary prospective payment system is another significant focus of value-based payment reforms. Although intended to promote efficiency by paying for pre-adamant diagnosis-based bundles of services, it does little to discourage unnecessary admissions and readmissions. Every bit such, hospitals at present receive payment penalties based on what CMS deems equally excess or unnecessary readmissions, also equally certain inappropriate hospital-acquired weather condition, such every bit surgical site infections following certain orthopedic procedures. These penalties come on top of other value-based adjustments tied to hospital performance on a wide range of process-of-care, issue, and patient experience metrics.
A broader effort to achieve higher value intendance aims to deconstruct the silos that be between dissimilar care settings, resulting in fragmentation and duplication of services. This is specially problematic at a time when individuals with v or more chronic conditions represent 22 percent of all Medicare beneficiaries, but 69 pct of all Medicare spending (http://health.usnews.com/health-news/all-time-practices-in-health/manufactures/2011/07/eighteen/fundamental-to-healthcare-costs-is-to-ameliorate-treat-chronically-ill). The ACA-authorized Center for Medicare & Medicaid Innovation (CMMI) continues to test and implement a growing portfolio of payment and service delivery models aimed at breaking down those silos and encouraging better care coordination. These include shared savings models for accountable care organizations that meliorate manage intendance across multiple settings, bundled payments within and across care settings for pre-divers episodes of care, and initiatives that take additional steps to reduce preventable hospital conditions and readmissions through the promotion of team-based approaches to care and smoother care transitions across settings.
The pursuit of high value care also resulted in an unprecedented investment in comparative effectiveness research (CER). The ACA-authorized Patient-Centered Outcomes Research Institute (PCORI) aims to ensure that both physicians and patients have more than meaningful and useful information regarding the comparative clinical effectiveness of unlike procedures and services and that these studies are conducted in a methodologically sound manner. This independent organization funded partially by the federal government and partially by private insurers is required to deport research in an open and transparent mode, disseminate its findings rapidly, and ensure that the needs of individuals and special populations are taken into consideration. Although PCORI cannot, under statute, brand recommendations to mandate or deny coverage based on price-effectiveness findings, CMS is still gratis to take evidence from comparative effectiveness studies into consideration when making coverage and reimbursement decisions.
While much of the focus is on the entire value equation, other initiatives do non pretend to be about anything other than toll control. For example, beginning in 2015, if Medicare toll growth exceeds a certain rate, the ACA-authorized Independent Payment Advisory Board (IPAB) must brand recommendations on how to reduce Medicare spending, and its proposals must exist fast-tracked through Congress. Although concerns have been raised about the IPAB's unrestricted power and its potential to arbitrarily limit patient access to necessary care, the President has yet to engage members due to slower than expected spending growth.
The federal authorities'south unprecedented investment in achieving a loftier-operation health system will likely have a lasting effect on the style medical care is delivered, evaluated, and paid for in our nation. Nonetheless, the sustainable impact of these reforms will depend heavily on achieving a balance between the needs of the patient, preserving the autonomy of the healthcare provider, and promoting responsible stewardship of health care dollars.
Limitations of value calculations in the spine population
The discussion thus far has focused on the economic and legislative imperatives for the measurement of value in spine care. Definitions of value (such as cost/QALY) and potential mechanisms to measure value (such as prospective registries including wellness utility and cost information) take been described, and the rationale for these mechanisms has been explained. While these concepts are valid, at that place are important practical considerations to take into account when measuring value which tin can dramatically change the conclusions reached when making value judgements. Important considerations to consider are the perspective from which the value equation is existence considered, the time frame of the value equation, the function of adventure stratification, and the utility of value judgements in making payment and policy decisions.
As alluded to above, value may be measured from the perspective of the payer, the private, or the order. Differences in measured value may exist dependent solely upon differences in the perspective from which the value is measured. A simplistic example is illustrated by Angevine and McCormick in a discussion regarding the cost effectiveness of anterior cervical discectomy and fusion (ACDF) with and without plate fixation. The authors causeless (based on a literature review) that there were no pregnant long term differences in effect between the ACDF and ACDF plus plate (ACDFP) groups. While both procedures were found to be cost constructive (using infirmary operative and peri-operative costs) in terms of toll per QALY, the ACDFP procedure was associated with a higher cost (the plate and its application price approximately $1500 at their center). From a payer perspective then, it would seem that ACDF without plate would be the procedure with higher value-same event at a lower price. From a patient or societal perspective however, the story is not and then clean cut. Based upon their institutional data and a literature review, the authors report that patients treated with ACDFP go back to work on average 3 weeks sooner than those treated with ACDF. Information technology is assumed that this difference is due to the surgeon'due south exercise of requiring patients without plate fixation to wearable a cervical collar for a period of fourth dimension following the performance, prohibiting driving and piece of work in most cases. If the lost income in those three weeks is more than $1500, then from a patient perspective, the ACDFP is the procedure with more than "value." Similarly, if the patient is able to produce more than than $1500 in goods and or services during those iii weeks, then society will besides benefit greater and observe greater value with the ACDFP option (39). Similar discussions now focus on minimally incisional spine surgery-particularly transforaminal interbody fusion techniques which generally crave more OR time but are associated with faster recovery when compared to traditional open techniques (40). When making judgments regarding the value of an intervention, it is extremely important to use the appropriate perspective. How the question is framed has a direct influence on the answer obtained.
A 2d important consideration is the fourth dimension frame used for the decision of "value." An expensive technique that is effective and durable will not appear to have value compared to a cheaper only less durable alternative unless the treatment effect is measured over an advisable period of time. For case, Soegaard et al performed a randomized controlled trial comparing postero-lateral fusion to circumferential fusion for axial back pain due to spondylolisthesis or degenerative disease (30). Both groups enjoyed substantial comeback in pain and functional consequence compared to their baseline measures. At two years, there were no significant differences between the groups in either physical (Figure 2A) or psychosocial (Fig. 2B) outcomes. Had the authors stopped their analysis at this point, they would take concluded that postero-lateral fusion was the more price effective option for this patient population (similar beneficial effect for less upfront costs). The authors continued to follow these patients for a menstruation of upwards to ix years. What they observed was a more durable improvement in the circumferential group which led to less health care costs and less societal costs-the exact opposite of what they would have ended if they had stopped the projection at two years. A major difference is illustrated in figure two, taken from the Soegaard paper, demonstrating a significantly larger proportion of patients working in the circumferential group compared to the postero-lateral group (Figure 3). Therefore, it is important to determine the appropriate timeframe for study of competing techniques for similar disease states. In a non-lethal condition such every bit low back pain, longer term studies may make sense. A caveat to this full general principle relates to opportunity toll of handling. A therapy that results in a rapid improvement in health status (microdiscectomy for example) may accept intrinsic value even if long term outcomes are similar to treatment alternatives which result in more than gradual improvement. Getting a patient back to work in six weeks versus six months is certainly worth a substantial upfront investment.
Figure two (from Soegaard, 2007):
Effigy iii (from Soegaard, 2007)
The adjacent issue to consider is the event of risk stratification. Abdu et al performed a review of the surgical arm of the SPORT report looking at the results of different surgical strategies for stenosis associated with spondylolisthesis (41). When these authors compared the results of different surgical strategies-non-instrumented fusion, instrumented postero-lateral fusion, and interbody fusion techniques, they found no significant differences in outcome. An uninformed review of this data might pb a patient, payer, or policy maker to conclude that the least expensive option (non-instrumented fusion) provides the virtually value (same result for less cost). Such an estimation is flawed withal because no data is provided regarding the rationale for the selection of a given surgical procedure for a given patient. Patients with stenosis and spondylolisthesis are not homogeneous-they differ in age, lifestyle, medical comorbidities and anatomy. A 40 year former truck driver with a mobile slip, tall disc space, and a history of smoking is unlikely to do well with an un-instrumented fusion (42) whereas a 78 year old sedentary widow with a collapsed disc space may do quite well with such an arroyo. The best interpretation of the Abdu information is that when experienced surgeons nowadays options to properly informed patients, the patient/surgeon team is able to cull appropriate procedures which are probable to work.
One of the most significant contributors to toll of a surgical procedure is a re-access or re-operation for a medical or surgical complication. A treatment strategy with a lower morbidity is mostly going to be more than cost constructive than ane with high morbidity if the efficacy of the two strategies is similar. Retrospective analysis of administrative databases is not helpful for making these types of judgements because patient characteristics and patient-reported outcomes are not available. If more severely symptomatic patients tend to be offered more ambitious interventions, so comparing complication rates or costs between the groups is meaningless. One way to begin to accost this effect is through the apply of hazard stratification.
Lee et al accept adult a calculator (spinesage.com) that can predict the risk of medical complications following spine surgery based on data available pre-operatively. Using a prospective registry, they identified take a chance factors for medical complications based on demographic, medical history, and approach specific variables (43). Using such a computer, it is possible to predict complications and costs for specific patient populations. This data, combined with patient reported outcomes, allows for the rational evaluation of true value.
Summary and Conclusion
"Value" is a popular buzzword in medicine and in spine intendance. Defining value is not an entirely straightforward do even so and it is critical that the interpretation of value be done in context. The context must include multiple perspectives when it comes to price and economic benefit, must include opportunity costs associated with the lack of treatment, and must include appropriate follow-upward and risk stratification. Not every spine surgeon needs to be an economist or wellness policy annotator, still all spine surgeons can contribute to the definition of value in spine care through participation in prospective registries which incorporate acceptable pre-operative risk assessment, accurate and complete complication reporting, and patient reported outcomes measures. Embracing what works and is valuable and discarding what is not effective or valuable is an easy concept to sympathise and an impossible one to fence with. It is our responsibility to plant the evidence base and to assistance payers and policy makers with rational interpretation of the evidence base.
Supplementary Material
SDC Table
Acknowledgments
Supported past AO Spine Northward America, Inc. Analytic support for this work was provided by Spectrum Inquiry, Inc., with funding from the AO Spine North America. National Institute for Arthritis, Musculoskeletal and Skin Diseases (P60AR062799) grant funds were received in support of this work. Relevant financial activities exterior the submitted piece of work: board membership, grants, patents.
References
i. Hoy D, March L, Brooks P, et al. The global burden of low back pain: estimates from the Global Brunt of Disease 2010 study. Ann Rheum Dis 2013. Ann Rheum Dis. doi: 10.1136/annrheumdis-2013-204428. [PubMed] [CrossRef] [Google Scholar]
2. Davis MA, Onega T, Weeks WB, Lurie JD. Where the United States spends its spine dollars: expenditures on different ambulatory services for the management of dorsum and cervix atmospheric condition. Spine. 2012 Sep 1;37(nineteen):1693–701. [PMC complimentary article] [PubMed] [Google Scholar]
3. Martin BI1, Deyo RA, Mirza SK, et al. Expenditures and health status among adults with back and neck problems. JAMA. 2008 Feb 13;299(6):656–64. doi: x.1001/jama.299.6.656. [PubMed] [CrossRef] [Google Scholar]
four. Strunk RG, Pfefer MT, Dube D. Multimodal chiropractic intendance of pain and disability for a patient diagnosed with benign joint hypermobility syndrome: a case report. J Chiropr Med. 2014 Mar;13(one):35–42. doi: 10.1016/j.jcm.2014.01.009. [PMC gratuitous article] [PubMed] [CrossRef] [Google Scholar]
v. Taber DJ, James GD, Jacon A. Manipulation nether anesthesia for lumbopelvic hurting: a retrospective review of 18 cases. J Chiropr Med. 2014 Mar;13(1):28–34. doi: 10.1016/j.jcm.2014.01.008. [PMC free commodity] [PubMed] [CrossRef] [Google Scholar]
6. Majchrzycki M, Kocur P, Kotwicki T. Deep tissue massage and nonsteroidal anti-inflammatory drugs for depression back pain: a prospective randomized trial. ScientificWorldJournal. 2014 February 23;2014:287597. doi: ten.1155/2014/287597. eCollection 2014. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
7. Wang XQ, Pi YL, Chen PJ, Chen BL, Liang LC, Li 10, Wang X, Zhang J. Whole torso vibration exercise for chronic low back hurting: written report protocol for a unmarried-blind randomized controlled trial. Trials. 2014 Apr two;15(1):104. doi: x.1186/1745-6215-15-104. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
8. Manchikanti L, Captain S, 2nd, Pampati V, Racz GB. Cost Utility Analysis of Percutaneous Adhesiolysis in Managing Pain of Post-lumbar Surgery Syndrome and Lumbar Central Spinal Stenosis. Pain Pract. 2014 Mar 26; doi: 10.1111/papr.12195. Epub ahead of print. [PubMed] [CrossRef] [Google Scholar]
9. Stuber KJ, Bruno P, Sajko S, Hayden JA. Core Stability Exercises for Low Dorsum Pain in Athletes: A Systematic Review of the Literature. Clin J Sport Med. 2014 Mar 20; Epub ahead of print. [PubMed] [Google Scholar]
10. Wald JT, Geske JR, Diehn Atomic number 26, Murthy NS, Kaufmann TJ, Thielen KR, Morris JM, Lehman V, Maus TP. A Practice Audit of CT-Guided Injections of Pars Interarticularis Defects in Patients with Centric Low Back Pain: A Primer for Further Investigation. Pain Med. 2014 Jan 21; doi: x.1111/pme.12344. Epub alee of impress. [PubMed] [CrossRef] [Google Scholar]
eleven. Ebadi S, Henschke N, Nakhostin Ansari Northward, Fallah E, van Tulder MW. Therapeutic ultrasound for chronic depression-back hurting. Cochrane Database Syst Rev. 2014 Mar;14:3, CD009169. doi: 10.1002/14651858.CD009169.pub2. [PubMed] [CrossRef] [Google Scholar]
12. Durmus D, Ulus Y, Alayli G, Akyol YC, Bilgici A, Yazicioglu Yard, Kuru O. Does microwave diathermy take an effect on clinical parameters in chronic low back pain? A randomized-controlled trial. J Back Musculoskelet Rehabil. 2014 Mar 10; Epub ahead of print. [PubMed] [Google Scholar]
13. Onat SS, Taolu O, Güneri FD, Oziler Z, Safer VB, Ozgirgin N. The effectiveness of balneotherapy in chronic depression back pain. Clin Rheumatol. 2014 Mar six; Epub alee of print. [PubMed] [Google Scholar]
fourteen. Eichen PM, Achilles N, Konig V, Mosges R, Hellmich K, Himpe B, Kirchner R. Nucleoplasty, a Minimally Invasive Process for Disc Decompression: A Systematic Review and Meta-analysis of Published Clinical Studies. Pain Physician. 2014 Mar-April;17(two):E149–73. [PubMed] [Google Scholar]
15. Ahmed R, Shakil-Ur-Rehman S, Sibtain F. Comparing betwixt Specific Lumber Mobilization and Cadre-Stability Exercises with Core-Stability Exercises Alone in Mechanical depression back pain. Pak J Med Sci. 2014 Jan;30(1):157–lx. doi: 10.12669/pjms.301.4424. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
16. Lee HJ, Seo JC, Kwak MA, Park SH, Min BM, Cho MS, Shin I, Jung JY, Roh WS. Acupuncture for depression back pain due to spondylolisthesis: study protocol for a randomized controlled airplane pilot trial. Trials. 2014 Apr 2;15(1):105. Epub alee of print. [PMC gratis article] [PubMed] [Google Scholar]
17. Miller West, Robinson LA, Lawrence RS, editors. Committee to evaluate measures of health benefits for environmental, health and safety regulation. Board on Health Care Services. Institute of Medicine of the National Academies. The National Academies Printing; Washington, DC: 2006. Valuing Health for regulatory cost-effectiveness assay. [Google Scholar]
18. Weinstein MC, Stason WB. Foundations of toll-effectiveness analysis for wellness and medical practices. Due north Engl J Med. 1977;296:716–721. [PubMed] [Google Scholar]
19. Pliskin JS, Shepard D, Weinstein MC. Utility functions for life years and health status. Operations Res. 1980;28:206–227. [Google Scholar]
xx. Gold M, Siegel J, Russell 50, et al. Cost-Effectiveness in Health and Medicine. New York: Oxford University Press; 1996. [Google Scholar]
21. Weinstein JN, Lurie JD, Tosteson TD, Zhao Due west, Blood EA, Tosteson AN, Birkmeyer N, Herkowitz H, Longley Thousand, Lenke L, Emery S, Hu SS. Surgical compared with nonoperative handling for lumbar degenerative spondylolisthesis. four-year results in the Spine Patient Outcomes Enquiry Trial (SPORT) randomized and observational cohorts. J Bone Joint Surg Am. 2009 Jun;91(six):1295–304. doi: x.2106/JBJS.H.00913. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
22. Weinstein JN, Lurie JD, Tosteson TD, Tosteson AN, Blood EA, Abdu WA, Herkowitz H, Hilibrand A, Albert T, Fischgrund J. Surgical versus nonoperative handling for lumbar disc herniation: four-year results for the Spine Patient Outcomes Research Trial (SPORT) Spine (Phila Pa 1976) 2008 December i;33(25):2789–800. doi: 10.1097/BRS.0b013e31818ed8f4. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
23. Weinstein JN, Tosteson TD, Lurie JD, Tosteson AN, Blood E, Hanscom B, Herkowitz H, Cammisa F, Albert T, Boden SD, Hilibrand A, Goldberg H, Berven S, An H SPORT Investigators. Surgical versus nonsurgical therapy for lumbar spinal stenosis. North Engl J Med. 2008 February 21;358(viii):794–810. doi: ten.1056/NEJMoa0707136. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
24. Burnett MG1, Stein SC, Bartels RH. Cost-effectiveness of current treatment strategies for lumbar spinal stenosis: nonsurgical care, laminectomy, and X-Terminate. J Neurosurg Spine. 2010 Jul;thirteen(1):39–46. doi: 10.3171/2010.3.SPINE09552. [PubMed] [CrossRef] [Google Scholar]
25. Riley GF. Administrative and claims records as sources of health care price information. Med Care. 2009 Jul;47(seven Suppl 1):S51–v. [PubMed] [Google Scholar]
26. Whitmore RG, Schwartz JS, Simmons S, et al. Performing a Price Analysis in Spine Outcomes Research: Comparing Ventral and Dorsal Approaches for Cervical Spondylotic Myelopathy. Neurosurgery. 2012;lxx:860–867. [PubMed] [Google Scholar]
27. Tosteson AN, Skinner JS, Tosteson TD, Lurie JD, Andersson GB, Berven South, Grove MR, Hanscom B, Blood EA, Weinstein JN. The cost effectiveness of surgical versus nonoperative treatment for lumbar disc herniation over two years: testify from the Spine Patient Outcomes Research Trial (SPORT) Spine (Phila Pa 1976) 2008 Sep 1;33(19):2108–15. [PMC free article] [PubMed] [Google Scholar]
28. Tosteson AN, Lurie JD, Tosteson TD, Skinner JS, Herkowitz H, Albert T, Boden SD, Bridwell G, Longley M, Andersson GB, Blood EA, Grove MR, Weinstein JN SPORT Investigators. Surgical handling of spinal stenosis with and without degenerative spondylolisthesis: price-effectiveness after 2 years. Ann Intern Med. 2008 Dec 16;149(12):845–53. [PMC free article] [PubMed] [Google Scholar]
29. Tosteson AN1, Tosteson TD, Lurie JD, et al. Comparative effectiveness evidence from the spine patient outcomes research trial: surgical versus nonoperative intendance for spinal stenosis, degenerative spondylolisthesis, and intervertebral disc herniation. Spine (Phila Pa 1976) 2011 Nov 15;36(24):2061–8. [PMC free article] [PubMed] [Google Scholar]
30. Soegaard R, Bünger CE, Christiansen T, Høy K, Eiskjaer SP, Christensen FB. Circumferential fusion is ascendant over posterolateral fusion in a long-term perspective: price-utility evaluation of a randomized controlled trial in severe, chronic low back pain. Spine (Phila Pa 1976) 2007 Oct 15;32(22):2405–14. [PubMed] [Google Scholar]
31. Cahill KS, Chi JH, Day A, Claus EB. Prevalence, complications, and hospital charges associated with use of bone-morphogenetic proteins in spinal fusion procedures. JAMA. 2009 Jul 1;302(ane):58–66. [PubMed] [Google Scholar]
32. Glassman SD, Carreon LY, Djurasovic M, Campbell MJ, Puno RM, Johnson JR, Dimar JR. RhBMP-2 versus iliac crest os graft for lumbar spine fusion: a randomized, controlled trial in patients over sixty years of age. Spine (Phila Pa 1976) 2008 December xv;33(26):2843–9. [PubMed] [Google Scholar]
33. Carreon LY, Glassman SD, Djurasovic G, Campbell MJ, Puno RM, Johnson JR, Dimar JR., 2nd RhBMP-2 versus iliac crest bone graft for lumbar spine fusion in patients over 60 years of historic period: a cost-utility report. Spine (Phila Pa 1976) 2009 Feb 1;34(3):238–43. doi: ten.1097/BRS.0b013e31818ffabe. [PubMed] [CrossRef] [Google Scholar]
34. Kohn Linda T, Corrigan Janet Thousand, Donaldson Molla S. To Err Is Human: Building a Safer Health System. Vol. 1. Washington, DC: Constitute of Medicine & Committee on Quality of Health Care in America; Nov 1, 1999. [Google Scholar]
35. New Study Estimates 8 Million American Families Experienced a Serious Medical or Drug Fault. The Commonwealth Fund; 2002. [Google Scholar]
36. Holahan J, Blumberg LJ, McMorrow Southward, Zuckerman S, Waidmann T, Stockley K. Health Policy Heart Occasional Paper. Washington, DC: The Urban Institute; 2011. Containing the Growth of Spending in the U.S. Health System. http://world wide web.urban.org/url.cfm?ID=412419. [Google Scholar]
37. Establish of Medicine. The healthcare imperative: Lowering costs and improving outcomes. Washington, DC: The National Academies Press; 2010. [Google Scholar]
39. Angevine PD, Zivin JG, McCormick PC. Cost-effectiveness of single-level anterior cervical discectomy and fusion for cervical spondylosis. Spine (Phila Pa 1976) 2005 Sep one;30(17):1989–97. [PubMed] [Google Scholar]
40. Singh K, Nandyala SV, Marquez-Lara A, Fineberg SJ, Oglesby M, Pelton MA, Andersson GB, Isayeva D, Jegier BJ, Phillips FM. A perioperative cost assay comparison unmarried-level minimally invasive and open transforaminal lumbar interbody fusion. Spine J. 2013 Nov 16; pii: S1529-9430(13)01723-three. [PubMed] [Google Scholar]
41. Abdu WA, Lurie JD, Spratt KF, Tosteson AN, Zhao West, Tosteson TD, Herkowitz H, Longely 1000, Boden SD, Emery S, Weinstein JN. Degenerative spondylolisthesis: does fusion method influence upshot? Four-yr results of the spine patient outcomes research trial. Spine (Phila Pa 1976) 2009 Oct 1;34(21):2351–sixty. [PMC free article] [PubMed] [Google Scholar]
42. Resnick DK, Choudhri TF, Dailey AT, Groff MW, Khoo L, Matz PG, Mummaneni P, Watters WC, 3rd, Wang J, Walters BC, Hadley MN American Association of Neurological Surgeons/Congress of Neurological Surgeons. Guidelines for the performance of fusion procedures for degenerative disease of the lumbar spine. Part 9: fusion in patients with stenosis and spondylolisthesis. J Neurosurg Spine. 2005 Jun;2(six):679–85. [PubMed] [Google Scholar]
43. Lee MJ1, Cizik AM2, Hamilton D2, Chapman JR. Predicting medical complications afterwards spine surgery: a validated model using a prospective surgical registry. Spine J. 2014 Feb 1;14(2):291–9. [PMC free article] [PubMed] [Google Scholar]
How Much Is A Service Call Disc Surgery Worth,
Source: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4487880/
Posted by: jacksontallay.blogspot.com
0 Response to "How Much Is A Service Call Disc Surgery Worth"
Post a Comment